John Perentesis

Title: John Perentesis: Innovator in Predictive Clinical Assays

Introduction

John Perentesis is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of medicine, particularly in the development of predictive clinical assays. His work focuses on improving treatment outcomes for individuals at risk of negative consequences from medical treatments.

Latest Patents

John Perentesis holds a patent for "Predictive clinical assays and methods of using same." This patent discloses methods for treating individuals at risk for negative outcomes associated with treatments for diseases, especially proliferative disorders like cancer. The method involves creating a predictive assay that incorporates both a biomarker and a genetic mutation. This predictive assay helps indicate the likelihood of adverse outcomes associated with specific treatments, allowing for more tailored and safer medical interventions.

Career Highlights

John Perentesis is affiliated with the Children's Hospital Medical Center, where he applies his expertise in clinical research and innovation. His work has been instrumental in advancing the understanding of how genetic factors can influence treatment efficacy and safety.

Collaborations

Some of his notable coworkers include Bruce Aronow and Rebekah Karns, who collaborate with him in various research initiatives aimed at enhancing patient care through innovative methodologies.

Conclusion

John Perentesis is a pioneering inventor whose work in predictive clinical assays is making a significant impact in the medical field. His contributions are helping to shape the future of personalized medicine and improve treatment outcomes for patients.